Jiangsu Run'an Pharmaceutical Co, Ltd., subsidiaria omnino possessa de Jiangsu Chiatai Qingjiang Pharmaceuticae Co, Ltd., modernus summus tech pharmaceuticus societas specialis in R&D, productionis et venditio fertilitatis ordinandae medicinae et varietatis APIs. Project constructionem mense Novembri 2018 incepit, LIX mu aream obtegens, cum tota obsidione 160 decies Yuan et tota area aedificium 25000 quadratum metrorum.
Nostra producta sunt Activa Ingrediens pharmaceutica (API), Pharmaceutical Medium, Tetrazole, Iminazole, Pyridine, Heterocyclica.
Praecipua activum medicamentum pharmaceuticum (API) producta: Hydrochloridem Gemcitabinum, Celecoxib, bromhexinum hydrochloridum, Iguratimod, Apremilast, Citrate Tofactinib, Crisaborole, Urapidil Hydrochloride, Sugammadex Natrium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium Bromidum, Finerenone, etc. elit mundi genus facti et productorum gignentium opificem per constantem emendationem et innovationem in technologiarum, et occasiones praeclarum negotium praebent sodalibus nostris per orbem terrarum. Munus nostrum ad praestantes operas emptores nobis permisit ut solidas relationes cum sociis nostris toto orbe extunderet.
T8 of Gemcitabine
Gemcitabine Intermedia 8
2-Deoxy-2,2-difluoro-D-erythro-pentofuranosum-3,5-dibenzoatum-1-methanesulfonatum
CAS 122111-11-9 media est pro Hydrochloride Gemcitabine.
T8 of Gemcitabine
Gemcitabine Intermedia 8
2-Deoxy-2,2-difluoro-D-erythro-pentofuranosum-3,5-dibenzoatum-1-methanesulfonatum
122111-11-9 media est pro Hydrochloride Gemcitabine.
T8 of Gemcitabine
Gemcitabine Intermedia 8
2-Deoxy-2,2-difluoro-D-erythro-pentofuranosum-3,5-dibenzoatum-1-methanesulfonatum
Gemcitabina T8 est media pro Hydrochloride Gemcitabine.
T9 of Gemcitabine
Gemcitabine Intermedia 9
CAS#134790-39-9 media est pro Hydrochloride Gemcitabino.
T9 of Gemcitabine
Gemcitabine Intermedia 9
CAS NO.134790-39-9 est pro Hydrochloride Gemcitabino intermedio.
T9 of Gemcitabine
Gemcitabine Intermedia 9
CAS 134790-39-9 media est pro Hydrochloride Gemcitabino.